130,667 Shares in Option Care Health, Inc. $OPCH Acquired by Phocas Financial Corp.

Phocas Financial Corp. bought a new stake in Option Care Health, Inc. (NASDAQ:OPCH) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 130,667 shares of the company’s stock, valued at approximately $4,163,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in OPCH. Cornerstone Planning Group LLC lifted its position in shares of Option Care Health by 7,621.4% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after purchasing an additional 1,067 shares during the period. McIlrath & Eck LLC acquired a new stake in shares of Option Care Health during the second quarter worth $37,000. Advisory Services Network LLC acquired a new stake in shares of Option Care Health during the third quarter worth $35,000. Caitong International Asset Management Co. Ltd bought a new position in Option Care Health during the third quarter worth $38,000. Finally, EverSource Wealth Advisors LLC raised its stake in Option Care Health by 528.1% during the second quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock worth $46,000 after buying an additional 1,183 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $27.47 on Monday. The firm has a market cap of $4.30 billion, a PE ratio of 21.46, a P/E/G ratio of 1.54 and a beta of 0.95. Option Care Health, Inc. has a 12-month low of $24.24 and a 12-month high of $36.80. The company’s fifty day simple moving average is $31.69 and its 200 day simple moving average is $30.68. The company has a quick ratio of 0.96, a current ratio of 1.53 and a debt-to-equity ratio of 0.87.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings results on Tuesday, February 24th. The company reported $0.46 earnings per share for the quarter, meeting the consensus estimate of $0.46. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. The firm had revenue of $1.47 billion during the quarter, compared to the consensus estimate of $1.46 billion. During the same period in the previous year, the firm posted $0.44 earnings per share. The business’s revenue was up 8.8% compared to the same quarter last year. As a group, sell-side analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. National Bank Financial set a $37.00 target price on shares of Option Care Health in a report on Tuesday, January 27th. Bank of America lifted their price objective on Option Care Health from $32.00 to $35.00 and gave the stock a “buy” rating in a research report on Tuesday, December 9th. Citigroup reissued an “outperform” rating on shares of Option Care Health in a research note on Tuesday, January 13th. Jefferies Financial Group restated a “buy” rating and set a $37.00 target price on shares of Option Care Health in a research report on Tuesday, January 13th. Finally, Morgan Stanley raised their target price on Option Care Health from $35.00 to $38.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 13th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, Option Care Health has a consensus rating of “Moderate Buy” and an average target price of $37.27.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.